Publications

2011 Publications
Author	Title of Paper	PubMed Link
Near AM et al	Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort	click to view
Emmanuel C et al	Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis	click to view
O'Mara TA et al	Progesterone receptor gene variants and risk of endometrial cancer	click to view
Helland A, Anglesio MS, George J et al	Deregulation of MYCN, Lin28B and Let7 in a molecular subtype of aggressive high-grade serous ovarian cancers	click to view
Nagle CM et al	Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer.	click to view
Amankwah EK et al	Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer	click to view
Goode EL et al	Xenobiotic-metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog.	click to view
Pearce CL et al	Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk	click to view
Amankwah EK et al	Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium
Zhang X et al	The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.

 

2010 Publications
Author	Title of Paper	PubMed Link
Doherty JA et al	ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.	click to view
Phelan CM et al	Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.	click to view
Verderio P et al	A BRCA1 promoter variant (rs11655505) and breast cancer risk.	click to view
Ahmed AA et al	Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.	click to view
Kolahdooz F et al	Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis.	click to view
Nagle CM et al	Tea consumption and risk of ovarian cancer	click to view
Gordon LG et al	Medical costs and outcomes for Australian women with ovarian cancer: a patient-level analysis over 2.5 years.	click to view
Nagle CM et al	Carbohydrate intake, glycemic load, glycemic index, and risk of ovarian cancer.	click to view
Johnatty SE et al	Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".	click to view
Ahmed AA et al	SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.	click to view
Gorringe et al	Copy number analysis identifies novel interactions between genomic loci in ovarian cancer.	click to view
Jordan SJ et al	Pathways to the diagnosis of epithelial ovarian cancer in Australia.	click to view
Bolton KL et al	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	click to view
Fletcher O et al	Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.	click to view
Goode et al	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	click to view
Kelemen LE et al	Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium	click to view
Price MA et al	Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers
Wiegand KC et al	ARID1A mutations in endometriosis-associated ovarian carcinomas.	click to view
Price MA et al	Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers	click to view
Wiegand KC et al	ARID1A mutations in endometriosis-associated ovarian carcinomas.	click to view
Milne RL et al	Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.	click to view
Beesley VL et al	Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life. Psycho-Oncology	click to view

 

2009 Publications
Author	Title of Paper	PubMed Link
Johnatty SE et al	The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.	click to view
Ahmed S et al	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	click to view
Dunning AM et al	Association of ESR1 gene tagging SNPs with breast cancer risk.	click to view
Etemadmoghadam D et al	Integrated Genome-wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemo-resistance in Ovarian Carcinomas.	click to view
Schildkraut JM et al	Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.	click to view
Gaudet MM et al	Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.	click to view
Johnatty SE et al	Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.	click to view
Milne RL et al	Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042	click to view
Pearce CL et al	Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.	click to view
Jordan SJ et al	Beyond Parity: Association of Ovarian Cancer With Length of Gestation and Offspring Characteristics.	click to view
Dick M-LB et al	Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review.	click to view
Price MA et al	Prevalence and predictors of insomnia in women with invasive ovarian cancer: Anxiety a major factor.	click to view
Song H et al	Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.	click to view
Song H et al	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.	click to view
Ibiebele TI et al	Reproducibility of food and nutrient intake estimates using a semi-quantitative FFQ in Australian adults.	click to view
Shah SP et al	Mutation of FOXL2 in granulosa-cell tumors of the ovary.	click to view

 

2008 Publications
Author	Title of Paper	PubMed Link
Merritt M et al	Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer
Pearce CL et al	Progesterone Receptor Variation and Risk of Invasive Epithelial Ovarian Cancer:  Results from the Ovarian Cancer Association Consortium Pooled Analysis. British Journal of Cancer (in press) delete
Ramus SJ et al	Consortium Analysis of Seven Candidate SNPs for Ovarian Cancer. Int J Cancer (delete)
Jordan SJ et al	Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis	click to view
Nagle CM et al	Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.	click to view
Lose F et al	Skewed X chromosome inactivation in breast and ovarian cancer status: Evidence for X-Linked Modifiers of BRCA1.	click to view
Garcia-Closas M et al	Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics	click to view
Frank B et al	Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.	click to view
Olsen CM et al	Epithelial ovarian cancer: testing the “androgens hypothesis”.	click to view
Olsen CM et al	Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.	click to view
Tothill et al	Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome.	click to view
Anglesio et al	Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.	click to view
Johnatty SE at al	ABCB1 (MDR1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.	click to view
Johnatty SE at al	No evidence that GATA3 rs570613 SNP modifies breast cancer risk.	click to view
Palmieri RT et al	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	click to view

 

2007 Publications
Author	Title of Paper	PubMed Link
Simon A Gayther	Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer
Susan J Jordan	Risk Factors for Benign Serous and Mucinous Epithelial Ovarian Tumors
Douglas F. Easton et al	Genome-wide association study identifies novel breast cancer susceptibility loci
Jonathan Beesley et al	Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from two Australian Studies and an additional validation set
Susan J Jordan et al	Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum?
Michael Krypuy et al	High resolution melting for mutation scanning of TP53 exons 5–8
Catherine M Olsen et al	Recreational Physical Activity and Epithelial Ovarian Cancer: A Case-Control Study, Systemic Review and Meta-analysis